Art

J-GLOBAL ID：201202210838688073   Reference number：12A0815446

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

顎骨壊死の発生率,リスク因子および転帰 骨転移有りの癌患者での3つの盲検実薬対照第III相試験の統合解析

Author (18)： SAAD F. (Univ. Montreal Montreal, CAN) ,  BROWN J. E. (Univ. Leeds, Leeds, GBR) ,  VAN POZNAK C. (Univ. Michigan Comprehensive Cancer Center, Ann Arbor, USA) ,  IBRAHIM T. (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ITA) ,  STEMMER S. M. (Rabin Medical Center, Beilinson Campus, Petah-Tiqva, ISR) ,  STOPECK A. T. (Univ. Arizona, Tucson, USA) ,  DIEL I. J. (Center for Comprehensive Gynecology, Mannheim, DEU) ,  TAKAHASHI S. (Cancer Inst. Hospital of JFCR, Tokyo, JPN) ,  SHORE N. (Carolina Urologic Res. Center, Myrtle Beach) ,  HENRY D. H. (Pennsylvania Hospital, Philadelphia, USA) ,  BARRIOS C. H. (Pontificia Universidade Catolica do Rio Grande do Sul School of Medicine, Rio Grande do Sul, BRA) ,  FACON T. (Hopital Claude Huriez, Lille, FRA) ,  SENECAL F. (Northwest Medical Specialties Tacoma, USA) ,  FIZAZI K. (Univ. Paris Sud, Villejuif, FRA) ,  ZHOU L. (Thousand Oaks, USA) ,  DANIELS A. (Thousand Oaks, USA) ,  CARRIERE P. (Thousand Oaks, USA) ,  DANSEY R. (Thousand Oaks, USA)
Material： Annals of Oncology  (Ann Oncol)
Volume： 23  Issue： 5  Page： 1341-1347  Publication year： May. 2012 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *denosmab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0815446&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (3)： Clinical application of other drugs acting on metabolism  (GW13070T) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Musculoskeletal diseases  (GG03000T)

Substance index (1)： Zoledronate

Reference (41)：

• Bamias A, Kastritis E, Bamia C et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005;23: 8580-8587.
• Cafro AM, Barbarano LA, Andriani A et al. Osteonecrosis of the jaw associated with chronic bisphosphonates therapy: an Italian experience. Blood (ASH Annual Meeting Abstracts) 2005; 106: (Abstr 5152).
• Dimopoulos MA, Kastritis E, Anagnostopoulos A et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 2006; 91: 968-971.
• Dimopoulos MA, Kastritis E, Moulopoulos LA et al. The incidence of osteonecrosis of the jaw (ONJ) in patients with multiple myeloma who receive biphosphonates depends on the type of biphosphonate. Blood (ASH Annual Meeting Abstracts) 2005; 106: (Abstr 637).
• Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005; 353: 99-102.

Terms in the title (11)： 顎骨壊死 ,  発生率 ,  リスク因子 ,  転帰 ,  骨転移 ,  癌患者 ,  盲 ,  薬 ,  対照 ,  第III相試験 ,  統合解析